๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Phase I/II Trial of Human Umbilical Cord Mesenchymal Stromal Cells for UDCA-Refractory Primary Biliary Cholangitis
NCT07795151Primary Biliary Cholangitis
Beijing 302 Hospital
Phase 1/2
68
Beijing
2026-08-31
Recruiting
Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration
NCT07776522Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
West China Hospital
Phase 2
50
Beijing, Jilin City, Chongqing, Shantou, Zhejiang, Harbin, Zhengzhou, Wuhan
2026-08-31
Recruiting
SKB565 for Injection in Advanced Solid Tumors
NCT07545265Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2
180
Guangzhou
2026-08-31
Recruiting
The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer
NCT07542379Prostate Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1
13
Wuxi
2026-08-31
Recruiting
This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.
NCT07649122Prostate Cancer
Norroy Bioscience Co., LTD
Phase 3
232
Nanjing, Wuxi
2026-08-31
Not yet open
Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma
NCT07701681ESCC, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University
Phase 2
75
Guangzhou
2026-08-31
Recruiting
To Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies
NCT07795034Head and Neck Cancer
Neuboron Bio-SciTech Co., Ltd.
Phase 2
35
Xiamen
2026-08-31
Not yet open
Rehabilitation With Wearable Monitors for Post-Lung Cancer Surgery
NCT07733492Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery
West China Hospital
Not applicable
126
Chengdu
2026-08-31
Not yet open
Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia
NCT07750730Trigeminal Neuralgia (TN)
Beijing Hospital of Traditional Chinese Medicine
Not applicable
60
Beijing
2026-08-31
Not yet open
Universal STAR-T Cell Injection in Autoimmune Kidney Diseases
NCT07746453IgA Nephropathy (IgAN), Primary Membranous Nephropathy
Guangdong Provincial People's Hospital
Not applicable
24
Guangdong
2026-08-31
Not yet open
A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 Monotherapy in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation
NCT07784374Pancreatic Cancer
Genfleet Therapeutics (Shanghai) Inc.
Phase 2
120
Shanghai
2026-08-31
Not yet open
A Prospective, Exploratory Study of Becotatug Vedotin Plus Putlimab for Neoadjuvant Therapy and Adjuvant Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07707167LA HNSCC
Jiangsu Cancer Institute & Hospital
Phase 2
35
Nanjing
2026-08-31
Not yet open
Hearing Intervention Effects on Brain and Language Development in Children With Bilateral Mild Hearing Loss
NCT07774728Hearing Loss, Bilateral
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
236
Shanghai
2026-08-31
Not yet open
Self-management Intervention for People With Cardiometabolic Multimorbidity: A Pilot Randomized Controlled Trial
NCT07792785Cardiometabolic Comorbidities
The Hong Kong Polytechnic University
Not applicable
72
Hong Kong
2026-08-31
Recruiting
Phase Ia Trial of HHK001 Compared With Enantone in Patients With Endometriosis
NCT07755956Endometriosis
Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.
Phase 1
30
Changsha
2026-08-31
Not yet open
Sphenopalatine Ganglion Acupuncture for Allergic Rhinitis
NCT07784491Allergic Rhinitis
Zhongshan Torch Development Zone People's Hospital
Not applicable
150
Zhongshan
2026-08-31
Not yet open
Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction
NCT07721545Perforating Artery Infarction, PAI
Neurodawn Pharmaceutical Co., Ltd.
Phase 2/3
944
Beijing
2026-08-31
Not yet open
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis
NCT07784816Atopic Dermatitis (AD)
Hangzhou Highlightll Pharmaceutical Co., Ltd
Phase 2/3
390
Beijing
2026-08-31
Not yet open
A Phase 2 Study of ABSK043 Combined With Osimertinib
NCT07710612Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive
Abbisko Therapeutics Co, Ltd
Phase 2
72
Guangzhou, Harbin, Wuhan, Shenyang, Shanghai, Taiyuan, Hangzhou
2026-08-31
Recruiting
Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
NCT07076836Lung Cancer (NSCLC), Immune Checkpoint Blockade, Electroacupuncture
West China Hospital
Not applicable
82
Chengdu
2026-08-31
Not yet open
A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.
NCT06970496Relapsed or Refractory B Cell Non Hodgkin Lymphoma
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Phase 1
48
Guangzhou, Nanchang, Shanghai, Wenzhou, Xi'an
2026-08-31
Not yet open
Serine/Glycine-Restricted Diet With Chemoradiotherapy for Rectal Cancer
NCT07811076Locally Advanced Rectal Cancer (LARC)
Xuelei Ma MD
Phase 1/2
140
Chengdu
2026-08-31
Not yet open
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PTT-121
NCT07768176Healthy Vollunteer
Pyrotech Therapeutics, Inc.
Phase 1
84
Beijing
2026-08-31
Not yet open
Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer
NCT07780721Esophageal Cancer
The Affiliated Hospital of Putian University
Phase 2
31
Putian
2026-08-30
Not yet open
A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma
NCT07758491PTCL, TRBC1 ADC, CTCL
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Phase 1/2
110
Beijing
2026-08-30
Not yet open
A Study for Postoperative Delirium in Older Patients With Intracranial Tumors
NCT07797660Delirium, Brain Tumor
Beijing Tiantan Hospital
Observational
164
Beijing
2026-08-30
Recruiting
Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia
NCT07188740DNMT3A Gene Mutation
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
32
Tianjin
2026-08-30
Not yet open
Pirtobrutinib+Sonrotoclax๏ผˆPS) Regimen in the Treatment of B-Cell Lymphoma
NCT07744750DLBCL - Diffuse Large B Cell Lymphoma, Richter Transformation, CLL / SLL, MZL
Changzhou No.2 People's Hospital
Phase 2
40
Nanjing
2026-08-30
Recruiting
Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL
NCT07778212DLBCL - Diffuse Large B Cell Lymphoma, Intermediate-High Risk, First-Line
The First Affiliated Hospital of Xiamen University
Not applicable
30
Xiamen
2026-08-30
Not yet open
Efficacy and Safety of Anrikefon Injection for Multimodal Postoperative Analgesia in Patients Undergoing Laparoscopic Hepatectomy
NCT07801183Postoperative Acute Pain
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 4
117
Guangzhou
2026-08-30
Recruiting
Clinical Trial of Thrombectomy Systems
NCT07749820Deep Vein Thrombosis (DVT)
BrosMed Medical Co., Ltd
Not applicable
167
Shanghai
2026-08-30
Not yet open
GKL-006Allo Injection in Patients With Advanced Solid Tumors
NCT07704515Solid Tumor Malignancies
Beijing Gene Key Life Technology Co., Ltd
Phase 1
27
Beijing
2026-08-30
Not yet open
Liposomal Bupivacaine vs Ropivacaine for Post-hemorrhoidectomy Analgesia
NCT07795203Resting Visual Analog Scale (VAS) Pain Score
Tongliao City People's Hospital
Phase 4
140
Neimeng
2026-08-30
Not yet open
A Clinical Trial Comparing the Efficacy and Safety of Anyoupingยฎ and Platinum-based Chemotherapy With or Without Enlituoยฎ in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
NCT07791745Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 2/3
362
Shanghai
2026-08-30
Not yet open
Safety, Tolerability, and Accuracy of a Hydrogel-Based Wearable Dynamic Intraocular Pressure Sensor in Healthy Adults
NCT07770178Intraocular Pressure
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
20
Shanghai
2026-08-30
Not yet open
A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal Cancer
NCT07750041Unresectable Advanced or Metastatic Colorectal Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1/2
260
Fujian
2026-08-30
Recruiting
Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma
NCT07796789Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 3
204
Guangzhou, Changsha, Fuzhou
2026-08-30
Not yet open
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants
NCT07765160Healthy Participants, Overweight or Obese Participants
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
96
Shanghai
2026-08-30
Not yet open
Impacted Tooth Management and Osteoradionecrosis Risk in NPC
NCT07764887Nasopharyngeal Carcinoma (NPC), Osteoradionecrosis of the Jaw
First Affiliated Hospital of Guangxi Medical University
Not applicable
536
Baise City, Beihai, Guigang, Guilin, Liuzhou, Nanning, Wuzhou, Yulin
2026-08-30
Not yet open
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes
NCT07755150Type 2 Diabetes Mellitus
Chendu DIAO Pharmaceutical Group CO., LTD.
Phase 2
272
Beijing
2026-08-30
Recruiting
A Clinical Study of FT1 in Patients With Short Bowel Syndrome
NCT07704047Short Bowel Syndrome, SBS
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 2
8
Nanjing
2026-08-30
Recruiting
A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism
NCT06819865Acute Pulmonary Embolism
Boston Scientific Corporation
Observational
30
Guangzhou
2026-08-30
Not yet open
Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum Disorder
NCT07809724Neuromyelitis Optica Spectrum Disorder (NMOSD)
Peking University People's Hospital
Phase 2
60
Beijing
2026-08-30
Not yet open
Night Driving After Trifocal Versus Monofocal IOL Implantation
NCT07755189Cataract, Presbyopia Correction
Jin Yang
Observational
200
Shanghai
2026-08-30
Not yet open
A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion
NCT07790419Liver Cancer
Zhai Wenlong
Phase 4
40
Zhengzhou
2026-08-30
Not yet open
Multi-Parameter Temporal Interference Stimulation in Patients With Epilepsy Undergoing SEEG Monitoring
NCT07790224Epilepsy
Beijing Sanbo Brain Hospital
Not applicable
60
Beijing
2026-08-30
Recruiting
A Study of BGM0504 in Early T2DM With Obesity
NCT07743983Type 2 Diabetes (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.
Phase 3
372
Nanjing
2026-08-30
Not yet open
Effects of Blood Flow Restriction Training on Neuromuscular Function and Performance in Artistic Jump Rope Athletes
NCT07750977Neuromuscular Function, Athletic Performance Enhancement
Shanghai University of Sport
Not applicable
30
Shanghai
2026-08-30
Not yet open
High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease
NCT07791979Hypoxemia, Gastric Cancer (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Esophageal Cancer
Zhejiang University
Not applicable
90
Hangzhou
2026-08-29
Not yet open
A Multicenter, Single Arm Study to Evaluate the Preliminary Efficacy and Safety Profile of Inavolisib in Previously Treated Pancreatic Ductal Adenocarcinoma Patients
NCT07694973Pancreatic Ductal Adenocarcinoma (PDAC)
Fudan University
Phase 2
62
Shanghai
2026-08-29
Not yet open
Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases
NCT07745257HR-positive, HER2-negative Metastatic Breast Cancer With Brain Metastases
Sun Yat-sen University
Phase 2
40
Guangzhou, Shijiazhuang, Anyang, Zhengzhou, Nanjing, Nanchang, Dalian, Chengdu
2026-08-28
Recruiting
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
NCT07778316Small Cell Lung Cancer
Amgen
Phase 3
400
Beijing, Shanghai
2026-08-28
Recruiting
Online Sharing for Head & Neck Cancer Support
NCT07766226Head and Neck Squamous Cell Carcinoma
West China Hospital
Not applicable
120
Chengdu
2026-08-28
Recruiting
A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08)
NCT07640789Non-small Cell Lung Cancer Stage III
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
418
Jinan
2026-08-28
Not yet open
Total Neoadjuvant mFOLFOX6 Plus Suvemcitug and Enlonstobart With Selective Omission of Pelvic Radiotherapy for High-Risk Mid-Rectal Locally Advanced Rectal Cancer
NCT07810114Rectal Cancer
Fudan University
Phase 2
52
Shanghai
2026-08-28
Not yet open
Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy
NCT07791550Pancreatic Neoplasms, Pancreatic Cancer, Drug-Related Side Effects and Adverse Reactions (MeSH Term)
Tianjin Medical University Cancer Institute and Hospital
Not applicable
96
Tianjin
2026-08-28
Not yet open
Five-Element Music Therapy for Psychological Distress in Pancreatic Cancer Chemotherapy
NCT07796906Pancreatic Neoplasms, Pancreatic Cancer, Anxiety, Depression and/or Anxiety Symptoms
Tianjin Medical University Cancer Institute and Hospital
Not applicable
320
Tianjin
2026-08-28
Recruiting
A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal Cancer
NCT07676162Advanced Colorectal Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
300
Beijing
2026-08-28
Recruiting
A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression
NCT07412262Non-Small Cell Lung Cancer
Guangdong Association of Clinical Trials
Phase 2
32
Guangzhou, Wuhan
2026-08-28
Recruiting
A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration
NCT07718165Solid Tumor (Phase I)
Abbisko Therapeutics Co, Ltd
Phase 1
247
Shanghai
2026-08-28
Recruiting
Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled Trial
NCT07576660Acute Respiratory Distress Syndrome (ARDS)
Southeast University, China
Phase 3
1,704
Nanjing
2026-08-27
Not yet open
Development and Pilot Application of a Solution-Focused Intervention for Social Isolation in Elderly Diabetic Foot Patients
NCT07787884Diabetic Foot Disease
Anhui Medical University
Not applicable
70
Hefei
2026-08-27
Recruiting
Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma
NCT07819656Nasopharyngeal Carcinoma (NPC), Myelosuppression
Nanfang Hospital, Southern Medical University
Observational
1,782
Guangzhou
2026-08-26
Not yet open
Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese Participants
NCT07779980Overweight , Obesity
Shanghai Minwei Biotechnology Co., Ltd
Phase 1
103
Kunming
2026-08-26
Recruiting
Aneurysm Treatment Using the Heli-FXโ„ข EndoAnchorโ„ข System China Study(ATHENA)
NCT07754318AAA - Abdominal Aortic Aneurysm
Medtronic Cardiovascular
Not applicable
142
Beijing
2026-08-26
Recruiting
A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer
NCT07735377Prostate Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
118
Guangzhou
2026-08-26
Recruiting
Artificial Intelligence Support for Stroke
NCT07785492Ischemic Stroke, Acute
Capital Medical University
Not applicable
516
Changsha
2026-08-26
Not yet open
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke
NCT07645560Ischemic Stroke
Beijing Tiantan Hospital
Phase 2
60
Beijing
2026-08-26
Recruiting
To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TUL321 Capsules in Healthy Participants.
NCT07760467Paroxysmal Nocturnal Hemoglobinuria, PNH
Zhuhai United Laboratories Co., Ltd.
Phase 1
94
Changsha
2026-08-26
Recruiting
A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors
NCT07730190Advanced Malignancies
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1
145
Hefei, Beijing, Fuzhou, Guangzhou, Harbin, Zhengzhou, Changsha, Shanghai
2026-08-25
Recruiting
Temporal Interference Stimulation Combined With Tai Chi for Mild Cognitive Impairment
NCT07799584Mild Cognitive Impairment (MCI)
Shanghai University of Sport
Not applicable
120
Shanghai
2026-08-25
Recruiting
GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma
NCT07795437Hepatocellular Carcinoma (HCC)
Peking University First Hospital
Not applicable
100
Beijing
2026-08-25
Not yet open
Pharmacokinetics of Huperzine A Oral Solution in Healthy Participants
NCT07784335Healhty
Wanbangde Pharmaceutical Group Co., LTD
Phase 1
40
Wenzhou
2026-08-25
Recruiting
A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
NCT07747857Type 2 Diabetes Mellitus Combined With Overweight or Obesity
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
72
Fuzhou, Guangzhou, Langfang, Luoyang, Wuhan, Yichang, Changsha, Nanjing
2026-08-25
Recruiting
Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy
NCT07347990Thrombotic Microangiopathy, Hematopoietic Stem Cell Transplantation (HSCT)
First Affiliated Hospital of Zhejiang University
Not applicable
30
Hangzhou
2026-08-25
Recruiting
A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBC
NCT07726992Papillary-Only Non-muscle-invasive Bladder Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
750
Beijing, Guangzhou
2026-08-25
Recruiting
A Study to Assess the Effectiveness and Safety of IPN10200 in Adult Chinese Participants With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
NCT07779252Moderate to Severe Glabellar Lines
Ipsen
Phase 3
160
Guangzhou, Changsha, Nanjing, Wuxi, Jingโ€™an, Chengdu, Hangzhou, Beijing
2026-08-25
Not yet open
Discovery and Validation of Biomarkers for Periodontitis, Dental Caries and Oral Squamous Cell Carcinoma
NCT07745803Oral Squamous Cell Carcinoma (OSCC), Periodontal Disease, Dental Caries
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
4,000
Shanghai
2026-08-25
Not yet open
A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglycerides
NCT07766759Healthy Adult Volunteers
Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.
Phase 1
24
Beijing
2026-08-25
Recruiting
A Randomized, Phase Ib, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SKB575 (HBM7575) in Participants With Asthma
NCT07732023Asthma (Diagnosis)
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
36
Chengdu
2026-08-25
Not yet open
Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic Dermatitis
NCT07683806Seborrheic Dermatitis
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
309
Bengbu, Wuhu, Fuzhou, Xiamen, Guangzhou, Shenzhen, Haikou, Baoding
2026-08-24
Not yet open
Phase 1 Clinical Study of GenSci164 Injection
NCT07790783Healthy Adult Trial Participants
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
56
Beijing
2026-08-24
Not yet open
VBC117First-in-Human Trial of VBC117 in Participants With Advanced Malignant Solid Tumors
NCT07772934Advanced Solid Tumors
VelaVigo Bio Inc
Phase 1/2
260
Zhejiang, Zhengzhou, Changsha, Nanchang, Shengyang, Shanghai, Taiyuan
2026-08-24
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
AstraZeneca
Phase 3
6,950
Baoding, Beijing, Bozhou, Changchun, Changde, Changsha, Chengdu, Chifeng
2026-08-24
Not yet open
Efficacy of Internet-based Cognitive Behavioral Therapy for Insomnia in Patients With Tinnitus and Insomnia
NCT07769515Tinnitus, Insomnia
Eye & ENT Hospital of Fudan University
Not applicable
168
Shanghai
2026-08-24
Not yet open
Electroencephalographic Trajectories During Emergence From Inhalational and Total Intravenous Anesthesia
NCT07806903Emergence From Anesthesia
Ruijin Hospital
Observational
140
Shanghai
2026-08-24
Recruiting
To Assess the Efficacy and Safety of Utilizing Galactose-deficient IgA1 Biomarker Changes to Guide Pathogenic IgA-targeted Therapeutic Strategies
NCT07822100IgA Nephropathy (IgAN), Henoch Schรถnlein Purpura Nephritis
Hong Zhang
Not applicable
374
Beijing
2026-08-24
Recruiting
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
NCT07797335Type 2 Diabetes, Cardiovascular Risk
Novo Nordisk A/S
Phase 3
1,778
Hefei, Beijing, Chongqing, Shenzhen, Cangzhou, Langfang, Shijiazhuang, Kaifeng
2026-08-24
Recruiting
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
NCT07776509Obesity or Overweight, Weight-Related Comorbidity, With/Without Diabetes Mellitus, Type 2
AstraZeneca
Phase 3
500
Beijing, Changchun, Chengdu, Guangzhou, Huzhou, Nanjing, Ningbo
2026-08-24
Not yet open
Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma
NCT07752394Head & Neck Cancer
Tang-Du Hospital
Phase 2
15
Xiโ€™an
2026-08-23
Recruiting
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China
NCT07710872Meningococcal Infection, Healthy Volunteers
Sanofi
Phase 3
4,568
Jingxi, Liuzhou, Tengzhou Town
2026-08-22
Not yet open
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
NCT07720193Advanced Extrapulmonary Neuroendocrine Carcinoma
Nanjing Leads Biolabs Co.,Ltd
Phase 3
280
Beijing, Fuzhou, Lanzhou, Guangzhou, Nanning, Harbin, Luoyang, Zhengzhou
2026-08-22
Not yet open
Segmentectomy Versus Lobectomy for Deep Solid-Dominant Early-Stage NSCLC
NCT07698990Non-Small Cell Lung Cancer, Stage IA Non-Small Cell Lung Cancer
Shanghai Chest Hospital
Not applicable
1,200
Shanghai
2026-08-21
Recruiting
A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
NCT07775404Obesity, Overweight
AstraZeneca
Phase 3
351
Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Hefei, Huangshi
2026-08-21
Recruiting
Obinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis
NCT07746180ANCA-Associated Glomerulonephritis (AAGN), ANCA-Associated Vasculitis (AAV)
Chinese PLA General Hospital
Phase 2
20
Beijing
2026-08-21
Not yet open
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
NCT07784270Obesity or Overweight, Diabetes Mellitus, Type 2
AstraZeneca
Phase 3
1,500
Beijing, Cangzhou, Changchun, Chengdu, Danyang, Ganzhou, Guangzhou, Huizhou
2026-08-21
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
NCT07753993Chronic Kidney Disease
AstraZeneca
Phase 3
7,000
Baoding, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chenzhou, Chongqing
2026-08-21
Not yet open
A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors
NCT07715747Solid Tumor, Metastatic Ovary Cancer, Metastatic Gastric Cancer, Metastatic Endometrial Carcinoma
TJ Biopharma Co., Ltd.
Phase 1
128
Shanghai
2026-08-21
Not yet open
Gut Microbiota and Tryptophan Metabolites in Parkinson's Disease
NCT07749261PARKINSON DISEASE (Disorder)
Ningxia Medical University
Observational
30
Laizhou
2026-08-20
Not yet open
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults
NCT07746726Neuromuscular Blockade
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
320
Changsha, Wenzhou
2026-08-20
Rows per page Showing 601–700 of 19052
Previous 5 6 7 8 9 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=7

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.